The national construction narrative for senior living this year is caution. A special issue brief prepared by The Weitz Co. for the American Seniors Housing Association describes 2026 project pipelines as moving with what its authors call "cautious stability," lengthening as financing and procurement get more scrutiny. That is the story most owners in the sector have heard all year.
It is not the story the Chicago closing table is telling. In the two weeks leading up to March 12, 2026, four Chicagoland senior living communities changed hands for a combined $217 million, and three of those four deals closed at a markup over their prior sale price, according to public records reported by The Real Deal. Since then, the pattern has held: Welltower, LCS Senior Living, a Skokie private equity firm, and a Lincolnwood operator have all traded Chicago-area assets at prices that don't match the "wait and see" tone coming out of the construction side of the industry.
The gap between those two stories is the actual signal for anyone weighing a sale in Chicagoland right now. It isn't that the market is universally hot. It's that specific, provable performance data is what's setting price, and owners who can document it are capturing markups regardless of what the broader financing environment looks like.
What the March deals actually priced
The clearest example is the sale of Clarendale of Mokena. LCS Senior Living, the Des Moines-based operator, sold the 156-unit community at 21536 South Wolf Road to Oak Brook-based Inland Real Estate Group for $72 million, a deal The Real Deal confirmed through public records. LCS had bought the property for $53 million in 2018 with a $34 million mortgage originally placed through Holliday Fenoglio Fowler, later acquired by JLL.
That's a markup of roughly 36 percent over an eight-year hold. What justified it wasn't a rising tide narrative. As of September 2025, the property was 98 percent occupied with a debt service coverage ratio of 2.3, meaning its net operating income was more than double its debt costs, according to loan tracking data from MorningStar cited in the same reporting.
A DSCR above 2.0 tells a buyer the asset can absorb a rate shock, a staffing cost spike, or a slow lease-up quarter and still cover its note. That's what a premium is actually buying.
Here is a snapshot of the named Chicagoland deals from the first half of 2026:
| Timing (2026) | Seller | Buyer | Asset | Price |
|---|---|---|---|---|
| March | LCS Senior Living | Inland Real Estate Group | Clarendale of Mokena, 156 units | $72 million |
| March | Cascade Capital Group | Alpine Healthcare (Ariel Gutnicki) | The Grove of Evanston and The Grove of the Lake | $33 million combined |
| May | Welltower | Pearl Healthcare | Hinsdale nursing home, 600 W. Ogden Ave | $21.5 million |
| July | Capitol Seniors Housing | Welltower | Arbor Terrace Highland Park and Arbor Terrace Glenview | $98 million combined |
| Reported July 2026 | Generations Healthcare Network | Aperion Care | Niles SNF, 6631 N. Milwaukee Ave | $29 million |
Five deals, five different buyer types, one common thread: none of them were priced off a regional average. Each one was priced off the trailing occupancy, debt coverage, and operating history of that specific building.
Welltower is buying and selling in the same metro at the same time
If you only read headlines, you'd assume a single REIT is either bullish or bearish on a market. Welltower's 2026 in Chicagoland is neither. In May, the company sold its Hinsdale nursing home at 600 West Ogden Avenue to Lincolnwood-based Pearl Healthcare for $21.5 million, according to The Real Deal's review of public records. Pearl Healthcare, led by Eittan Zeffran, already operates more than a dozen nursing homes and skilled nursing facilities across the Chicago area.
Two months later, Welltower turned around and bought Arbor Terrace Highland Park and Arbor Terrace Glenview from Capitol Seniors Housing for $58 million and $40 million, ending what The Real Deal described as its own Chicagoland selling streak. Same company, same metro, opposite sides of the ledger inside a single quarter.
The through-line is the asset type, not the geography. Welltower sold a skilled nursing property and bought private-pay assisted living communities. That mirrors what National Health Investors announced at a national scale in April 2026: an agreement to sell 32 skilled nursing facilities to National HealthCare Corporation for $560 million, a deal NHI said would push its skilled nursing exposure down to roughly 12.2 percent of total investments while its private-pay Senior Housing Operating Portfolio grows to about 22 percent, a shift the company has tied to its view that private-pay senior housing is the higher-quality asset class going forward.
For a Chicago owner, this matters less as macro trivia and more as a targeting question. If you own a skilled nursing asset, the large public REITs are, on balance, sellers of that product right now, not buyers. If you own assisted living or memory care, they're actively shopping.
The buyers stepping into skilled nursing are local
Someone still has to buy the skilled nursing assets the REITs are shedding, and in Chicagoland that someone is increasingly a regional operator rather than an institution. Cascade Capital Group, a Skokie-based private equity firm, sold two post-hospital rehabilitation properties, The Grove of Evanston and The Grove of the Lake, for $33 million combined. The buyer was Alpine Healthcare, a company founded this year by Ariel Gutnicki, a Skokie-based health care executive who previously worked at Pearl Healthcare and Legacy Healthcare, both established rehabilitation and skilled nursing operators in the region.
The same pattern shows up in Niles, where Lincolnwood-based Generations Healthcare Network sold a skilled nursing facility it had held since 2014 to Chicago-based Aperion Care for $29 million.
Neither buyer is a public REIT or a national institution. Both are Illinois-based operators who understand the state's licensing structure and staffing market well enough to underwrite a deal a REIT would rather not hold. If you're a Chicago-area SNF owner planning an exit, this is the buyer pool your marketing process should be built around, not the institutional capital that's currently rotating toward assisted living and memory care.
Where the caution is real
None of this means every Chicago senior care asset is trading at a premium. A portfolio of medical offices and a safety net hospital in Chicago and west suburban River Forest have been tied up in litigation since a lawsuit filed in December 2025 over $89 million in unpaid debt. Resilience Healthcare allegedly defaulted on a $67 million loan note, and former Pipeline Health affiliates claim they reacquired the properties through a credit bid after that default. Among the casualties was Weiss Memorial Hospital, which Resilience shut down after its Medicaid reimbursement was terminated over compliance issues.
That situation is a useful check on the thesis, not a contradiction of it. The distress there traces to leverage and compliance failures at the operator level, not to weak underlying demand for senior care in Chicago. It's the same lesson the Mokena and Niles deals teach from the other direction: buyers in this market are underwriting the specific building and the specific operator, and they'll price both a premium and a discount accordingly.
What this means if you're weighing an exit
The practical takeaway for an owner-operator, a not-for-profit board, or a lender holding a Chicagoland asset is that the "is now a good time to sell" question is the wrong one. The better question is whether your trailing occupancy, your DSCR, and your compliance record would hold up under the kind of scrutiny that produced a 36 percent markup in Mokena, or the kind that sank the River Forest portfolio. That's a diagnostic you can run before you go to market, and it's a large part of what a formal broker's opinion of value is designed to surface.
Financing structure matters here too. Skilled nursing and private-pay product don't move through the same lenders or the same buyer pools, a distinction we walk through in more detail in our guide to financing paths for Chicago-area senior living buyers. Knowing which lane your asset sits in before you start marketing it shapes who you should be talking to.
FAQ
Does a markup sale mean Chicago senior living values are up across the board? Not evenly. The premiums in the deals above tracked specific occupancy and debt service coverage numbers at each property, not a rising tide across the metro. A building with weaker trailing performance in the same submarket would be priced very differently.
Are large REITs still buying skilled nursing in Chicago? The 2026 pattern points the other way. Welltower sold a Hinsdale skilled nursing facility while buying two assisted living communities in the same stretch, and NHI's national portfolio sale announced in April 2026 is deliberately reducing its skilled nursing share in favor of private-pay senior housing. Regional operators, not REITs, are the more active buyers of Chicago skilled nursing assets right now.
Does the Resilience Healthcare situation reflect a broader problem in the Chicago market? The reporting ties that default and the Weiss Memorial closure to leverage and Medicaid compliance issues specific to that operator and portfolio, not to a market-wide downturn. It's a reminder that underwriting happens at the asset and operator level even in an active deal environment.
If you're trying to figure out where your own Chicago-area community sits in this picture, before or instead of listing it, Senior Living Investment Brokerage can walk through a confidential Broker's Opinion of Value built on exactly the kind of trailing performance data this market is actually pricing.
